CHENGDA PHARMA's shareholder Qianhai Shengtai plans to reduce its holdings by no more than 3.23%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, CHENGDA PHARMA announced that its shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) (referred to as "Qianhai Shengtai") plans to reduce its holdings of the company's shares through block trading by no more than 4.8949 million shares (accounting for 3.23% of the total share capital after excluding the shares in the repurchase special account) within three months from the 15 trading days following the disclosure of this announcement (from May 30, 2025, to August 29, 2025)
According to the Zhitong Finance APP, CHENGDA PHARMA (301201.SZ) announced that its shareholder Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) (referred to as "Qianhai Shengtai") plans to reduce its holdings of the company's shares through block trading within three months after 15 trading days from the date of this announcement (from May 30, 2025, to August 29, 2025), not exceeding 4.8949 million shares (accounting for 3.23% of the total share capital after excluding the shares repurchased by the company)